Prelims reveal performance in line with expectations, with EBITDA of £4.8m (vs £4.6mE) from revenue of £17.2m (vs £17.0mE), as per the August trading update. Net cash was £1.5m (FY14: £1.6m), after £1.1m free cash flow before acquisition dividend cash outflow. Consistent group deal volumes delivered organic growth of 12.6% in the core business and 10.3% across the acquisitions. FY16 EBITDA forecasts are lifted 8%, acquisitions are integrated, and the
13 Oct 2015
Growth and potential
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Growth and potential
- Published:
13 Oct 2015 -
Author:
Andrew Darley - Pages:
Prelims reveal performance in line with expectations, with EBITDA of £4.8m (vs £4.6mE) from revenue of £17.2m (vs £17.0mE), as per the August trading update. Net cash was £1.5m (FY14: £1.6m), after £1.1m free cash flow before acquisition dividend cash outflow. Consistent group deal volumes delivered organic growth of 12.6% in the core business and 10.3% across the acquisitions. FY16 EBITDA forecasts are lifted 8%, acquisitions are integrated, and the